NEW YORK (GenomeWeb) – Dutch informatics firm Bluebee today announced it has raised €1.8 million ($1.9 million) in financing from Buysse & Partners and Delft University of Technology.
The Delft University of Technology and Imperial College London spinout offers a cloud-based supercomputing hardware and software platform to increase both sequencing capacity and speed. The firm said it would use the funds to help sell its platform to clinicians and laboratories.
"Our technology solves the biggest bottleneck in DNA analysis today and will help save lives by bringing real-time, personalized medicine one step closer," Bluebee CEO Hans Cobben said in a statement. "We enable virtually unlimited scaling up of sequencing capacity, which is a first in this industry."
Bluebee's hybrid-core computing technology also leads to a significantly shortened time-to-diagnosis for clinical laboratories, the firm said.